<<

JOURNAL OF THE LOUISIANA STATE MEDICAL SOCIETY CLINICAL CASE OF THE MONTH A 44-Year-Old Woman with Rash

H. Martin Plauche, BS, Stephen Lambert, BS, Stratton Grisoli, MD, Skylar Souyoul, MD, Shane Guillory, MD, Fred A. Lopez, MD

In recent years, the immunomodulating agent has been increasingly used as a cutting agent in . This contaminant has led to numerous reported cases of levamisole-induced vasculopathy. With the increased use of levamisole-adulterated cocaine, physicians should be aware of the various cutaneous manifestations associated with levamisole toxicity. We describe the case of a chronic cocaine user who presented with extensive hemorrhagic retiform purpura involving the ears, upper extremities, and trunk. Levamisole- induced vasculopathy should always be included in the differential diagnosis of a patient with evidence of and history of cocaine abuse. This case emphasizes the importance of timely recognition and proper counseling in order to prevent recurrent episodes of levamisole-induced skin necrosis.

INTRODUCTION

A 44-year-old woman with a past medical history of untreated, also revealed a microcytic anemia with hemoglobin levels chronic hepatitis C presented to the emergency room with acute of 10.6 GM/DL (12-16 GM/DL), and a MCV of 74.7 FL (80-100 onset of a widespread rash on her bilateral helices, abdomen, FL). Inflammatory markers were elevated with a C-reactive buttocks, and bilateral upper extremities. She was initially seen protein level of 12.6 MG/DL (<0.90 MG/DL) and an erythrocyte at an outside hospital one week prior where she was treated sedimentation rate of 67 MM/HR (0-20 MM/HR ). Blood cultures with topical permethrin for a presumptive diagnosis of scabies. and HIV tests drawn at admission returned negative. Toxicology Subsequently, the tender lesions which had appeared initially screening of the urine was positive for cannabinoids, cocaine, on her abdomen and right upper extremity quickly spread to and levamisole. involve the buttocks, posterior thighs, and external ears. She returned to the hospital and was given an additional dose Based on the patient’s recent cocaine use and the characteristic of permethrin cream and . However, the patient’s clinical presentation, a presumptive diagnosis of levamisole- cutaneous lesions did not improve and continued to evolve into induced vasculitis was made. Further immunological workup larger more necrotic plaques. At that point, she presented to our revealed positive p-ANCA antibodies with a titer of 1:640 (<1:20 facility. On further evaluation, she admitted to cocaine use on titer). C3 complement levels were within normal range, however the night prior to onset of her skin findings. She also endorsed a low C4 complement of 17 MG/DL (18-55 MG/DL) was present. history of a similar purpuric eruption that occurred on both Additional laboratory tests that were negative included: lower extremities three years prior after cocaine use. cryoglobulins, c-ANCA, anticardiolipin panel, rheumatoid factor, antinuclear antibodies, and an extractable nuclear antigen (ENA) Her vital signs upon presentation included a temperature 98.8 panel. Dermatology was consulted, and a punch biopsy of a °F, blood pressure 137/79 mmHg, heart rate 112 beats per purpuric lesion on the left forearm was obtained. Histopathology minute, respiratory rate 18 breaths per minute, and a body mass of the punch biopsy revealed multiple fibrin thrombi distributed index of 26.9. Physical examination revealed large, retiform, throughout the superficial and deep dermis. Dermal hemorrhage purpuric plaques with erythematous, inflammatory borders and along with perivascular neutrophilic inflammation was also central hemorrhage and necrosis (Figure 1). Lesions involved present. Treatment consisted of supportive care and complete the bilateral helices of the ears (Figure 2), bilateral upper withdrawal of cocaine. The patient’s lesions slowly improved, arms, forearms, buttocks, and posterior thighs. Multiple faintly and she was discharged home following counseling on the hyperpigmented to violaceous macules were scattered over her importance of cocaine cessation. abdomen and back (Figure 3). The purpuric lesions had a stellate pattern with a notable central necrosis. EPIDEMIOLOGY

Laboratory analysis revealed a leukopenia with a WBC count of Drug-induced vasculitis is one of the most common causes of 3,000 per UL (4,500-11,000 per UL), with an absolute neutrophil vasculitis in adults. It can be a diagnostic challenge to differentiate count of 1900 per UL (1800-8000 per UL). Laboratory workup between the various idiopathic cutaneous vasculopathies. Illicit

140 J La State Med Soc VOL 169 SEPTEMBER/OCTOBER 2017 JOURNAL OF THE LOUISIANA STATE MEDICAL SOCIETY drug use in the United States has been steadily increasing and Levamisole is an immunomodulatory drug, developed in in 2013 up to 24.6 million Americans reported the use of an illicit the 1960s, that was initially used as an adjuvant agent in the drug in the past month.1 Cocaine abuse is widespread in our treatment of colorectal and rheumatoid arthritis.3,6 society with over 5 million Americans using some form of the The first case of cutaneous necrotizing vasculitis caused by drug.2 levamisole was described in 1978.4 It was subsequently banned due its severe side-effect profile which included and vasculitis.5,6 It is now currently used as an agent in veterinary medicine.6 In recent years, levamisole has been used as a bulking agent in cocaine due to its physical similarities and its ability to potentiate the effects of cocaine. It has been thought to potentiate the stimulatory effects of cocaine by increasing the amount of dopamine in the brain and having effects. According to U.S. Drug Enforcement Agency (DEA) estimates, up to 69% of cocaine imported into the United States is contaminated with levamisole.7

In 2009 the Centers for Disease Control and Prevention (CDC) first reported the link between agranulocytosis and cocaine 5 Figure 1: Right Arm: Large, retiform, centrally necrotic, purpuric plaque on abuse , and in 2010, the first case of levamisole-induced 8 the right upper extremity with surrounding background of inflammation vasculitis in a cocaine abuser was reported. Over the following and erythema. years, a rise in the number of cases of levamisole-induced vasculitis has been reported. According to previous reports, levamisole-induced cutaneous vasculitis is more commonly seen in women with a median age of 45 years.9 The pathogenesis of levamisole-induced necrotizing vasculitis is still unknown, but some postulate that immune complexes are formed. A common theory is that the induced autoantibodies stimulate immune cells to release cytotoxic agents causing cellular destruction.10 With the widespread use of levamisole-adulterated cocaine, early recognition of levamisole-induced vasculitis is important in order to prevent recurrent episodes in the future that can lead to significant complications.

CLINICAL PRESENTATION AND DIAGNOSIS

Levamisole-induced Vasculitis (LIV) presents with a unique clinical picture that is characterized by reticulated purpuric Figure 2: Hemorrhagic, purpuric plaque with surrounding rim of lesions and hemorrhagic bullae with concurrent central necrosis 9 inflammatory erythema involving the right helix and lobule. occurring most commonly on the lower extremities and ears. The predilection for the ears is a specific finding for LIV and is thought to possibly arise due to the lower temperature and smaller vessels favoring the deposition of immune complexes.10 These necrotizing vasculitic lesions with an erythematous base are also found on the upper extremities, trunk, face, nose, and oral region.11 Arthralgias of the large joints are commonly reported clinical manifestations. Many patients also have constitutional symptoms including fever, weight loss, night sweats, myalgia, and malaise.12 Rhinorrhea and recurrent sinusitis have also been reported, most likely related to the nasal inhalation of cocaine.

Levamisole has immunomodulatory effects that lead to the increase of multiple autoantibodies. Elevated Perinuclear ANCA (p-ANCA) has the strongest association in LIV, with cytoplasmic ANCA (c-ANCA), anti-myeloperoxidase (anti-MPO), anti-proteinase-3 (anti-PR3) and human neutrophil elastase Figure 3: Numerous, faintly hyperpigmented to violaceous macules antibodies also elevated in some patients. Studies have also scattered over mid and upper back. shown elevated titers of lupus anticoagulant, antinuclear,

J La State Med Soc VOL 169 SEPTEMBER/OCTOBER 2017 141 JOURNAL OF THE LOUISIANA STATE MEDICAL SOCIETY anti-cardiolipin, and anti-double-stranded DNA antibodies.12 associated vasculitis. Nephrology 2009; 14:33–41. Of note, a number of other drugs including propylthiouracil, 14. Nolan AL and Jen KY. Pathologic manifestations of levamisole-adulterated hydralazine, and minocycline have also been associated with cocaine exposure. Diagn Pathol 2015; 10:48. 15. Pearson T, Bremmer M, Cohen J, et al. Vasculopathy related to cocaine 13 ANCA-associated vasculitis. Other common laboratory findings adulterated with levamisole: A review of the literature. Dermatol Online J of LIV include agranulocytosis and . 2012; 18(7):1.

Histopathologic evaluation of skin biopsy in LIV typically H. Plauche and S. Lambert are both fourth-year medical students at Louisiana reveals a leukocytoclastic vasculitis of the small vessels as well State University Health Sciences Center School of Medicine in New Orleans. as vasculopathic features including intravascular thrombi.14 Dr. Grisoli is a second-year Resident in Dermatology in the Department of There is a predominantly neutrophilic inflammatory infiltrate Dermatology at LSUHSC-New Orleans. Dr. Souyoul is a third-year Resident in Dermatology in the Department of Dermatology at LSUHSC-New Orleans, that invades the vessel walls spreading into the perivascular Louisiana. Dr. Guillory is an Assistant Professor in the Department of Medicine area. A high number of eosinophils is also a common finding. at LSUHSC-New Orleans. Dr. Lopez is the Richard Vial Professor and Vice Chair Fibrinoid necrosis along with the extravasation of red blood cells for Education in the Department of Medicine at LSUHSC-New Orleans, Louisiana. is frequently seen as well.9

MANAGEMENT

Treatment of levamisole-induced cutaneous vasculitis requires supportive care and counseling on cocaine cessation which, in most cases, leads to resolution of symptoms. There is no strong evidence that steroids are needed for the treatment of LIV cutaneous lesions.15 Steroid use should be withheld due to the possibility of infections in patients who are neutropenic. Patients must be educated on the recurrence of the necrotizing lesions if cocaine use is resumed. In some patients, extensive tissue involvement can lead to amputation and severe infection.5

REFERENCES

1. National Institute on Drug Abuse. Nationwide Trends. (accessed May 21, 2016). 2. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. (accessed May 21, 2016). 3. Amery WK and Bruynseels JP. Levamisole, the story and the lessons. Int J Immunopharmacol 1992; 14(3): 481-486. 4. Macfarlane DG and Bacon PA. Levamisole-induced vasculitis due to circulating immune complexes. Br Med J 1978; 1(6110): 407-408. 5. Centers for Disease Control and Prevention. Agranulocytosis associated with cocaine use - four States, March 2008-November 2009. MMWR Morb Mortal Wkly Rep 2009; 58(49):1381-1385. 6. Symoens J, Veys E, Mielants M, Pinals R. Adverse reactions to levamisole. Cancer Treat Rep 1978; 62(11): 1721-1730. 7. Chang A, Osterloh J, Thomas J. Levamisole: a dangerous new cocaine adulterant. Clin Pharmacol Ther 2010; 88(3):408-411. 8. Bradford M, Rosenberg B, Moreno J, Dumyati G. Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole. Ann Intern Med. 2010; 152(11):758-759. 9. Czuchlewski DR, Brackney M, Ewers C, et al. Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine. Am J Clin Pathol 2010; 133(3):466-472. 10. Rongioletti F, Ghio L, Ginevri F, et al. Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol 1999; 140(5):948-951. 11. Arora, NP. Cutaneous vasculopathy and neutropenia associated with levamisole-adulterated cocaine. Am J Med Sci 2013; 345(1):45-51. 12. Graf J, Lynch K, Yeh CL, et al. Purpura, cutaneous necrosis, and antineutrophil cytoplasmic antibodies associated with levamisole-adulterated cocaine. Arthritis Rheum 2011; 63(12):3998-4001. 13. Gao Y, Zhao MH. Drug-Induced anti-neutrophilic cytoplasmic anti-body

142 J La State Med Soc VOL 169 SEPTEMBER/OCTOBER 2017